Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors
- 4 February 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 6 (3), 344-348
- https://doi.org/10.1021/ml500521r
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- DengueThe New England Journal of Medicine, 2012
- Inhibition of Dengue Virus by Targeting Viral NS4B ProteinJournal of Virology, 2011
- A Translation Inhibitor That Suppresses Dengue Virus In Vitro and In VivoAntimicrobial Agents and Chemotherapy, 2011
- Inhibition of Dengue Virus through Suppression of Host Pyrimidine BiosynthesisJournal of Virology, 2011
- Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of MalariaJournal of Medicinal Chemistry, 2010
- An adenosine nucleoside inhibitor of dengue virusProceedings of the National Academy of Sciences of the United States of America, 2009
- The Medicinal Chemistry of Dengue FeverJournal of Medicinal Chemistry, 2009
- Three-component condensation of 5-aminopyrazole derivatives with isatins and Meldrum’s acid. Synthesis of 1,7-dihydrospiro[pyrazolo[3,4-b]-pyridine-4,3′-indole]-2′,6(1′H,5H)-dionesRussian Chemical Bulletin, 2009
- A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral DrugsThe Journal of Infectious Diseases, 2007
- Synthesis of 7,8-dihydro-6H-pyrazolo[3,4-b]quinolin-5-ones and related derivativesJournal of Heterocyclic Chemistry, 1991